The pathogenic potential of campylobacter concisus strains associated with chronic intestinal diseases

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Kaakoush, Nadeem O ^a   Deshpande, Nandan P ^a   Wilkins, Marc R ^a   Tan, Chew Gee ^a   Burgos Portugal, Jose A ^a   Raftery, Mark J ^a   Day, Andrew S ^b,c   Lemberg, Daniel A ^c   Mitchell, Hazel ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; CYTOKINE; MUCIN; PROTEOME;

ACUTE DISEASE; ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL FLAGELLUM; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM ISOLATION; CAMPYLOBACTER; CAMPYLOBACTER CONCISUS; CELL DAMAGE; CHEMOTAXIS; CHILD; CHRONIC DISEASE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DOWN REGULATION; ENTEROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; GASTROENTERITIS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE BIOPSY; MALE; NONHUMAN; PRESCHOOL CHILD; PROTEIN EXPRESSION; PROTEOMICS; SCHOOL CHILD; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; BACTERIAL GENE; BIOLOGICAL MODEL; BIOPSY; BIOSYNTHESIS; CAMPYLOBACTERIOSIS; CELL STRAIN CACO 2; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; ULTRASTRUCTURE;

ADOLESCENT; BACTERIAL ADHESION; BIOPSY; CACO-2 CELLS; CAMPYLOBACTER; CAMPYLOBACTER INFECTIONS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYTOKINES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENES, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; INTESTINAL DISEASES; INTESTINAL MUCOSA; MALE; MODELS, BIOLOGICAL; MUCINS; PHENOTYPE; PLASMIDS; POLYMERASE CHAIN REACTION; PROTEOME;

EID: 83355170686     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029045     Document Type: Article

References (58)

1. Cho JH, Abraham C, (2007) Inflammatory bowel disease genetics: Nod2. Annu Rev Med 58: 401-416.
2. Theodossi A, Spiegelhalter DJ, Jass J, Firth J, Dixon M, et al. (1994) Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut 35: 961-968.
3. Sartor RB, (2006) Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3: 390-407.
4. Engberg J, On SL, Harrington CS, Gerner-Smidt P, (2000) Prevalence of Campylobacter, Arcobacter, Helicobacter, and Sutterella spp. in human fecal samples as estimated by a reevaluation of isolation methods for Campylobacters. J Clin Microbiol 38: 286-291.
5. On SL, (1996) Identification methods for campylobacters, helicobacters, and related organisms. Clin Microbiol Rev 9: 405-422.
6. Zhang L, Man SM, Day AS, Leach ST, Lemberg DA, et al. (2009) Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease. J Clin Microbiol 47: 453-455.
7. Man SM, Zhang L, Day AS, Leach ST, Lemberg DA, et al. (2010) Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease. Inflamm Bowel Dis 16: 1008-1016.
8. Man SM, Kaakoush NO, Leach ST, Nahidi L, Lu HK, et al. (2010) Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species. J Infect Dis 202: 1855-1865.
9. Kaakoush NO, Man SM, Lamb S, Raftery MJ, Wilkins MR, et al. (2010) The secretome of Campylobacter concisus. FEBS J 277: 1606-1617.
10. Aabenhus R, Permin H, On SL, Andersen LP, (2002) Prevalence of Campylobacter concisus in diarrhoea of immunocompromised patients. Scand J Infect Dis 34: 248-252.
11. Sainsus N, Cattori V, Lepadatu C, Hofmann-Lehmann R, (2008) Liquid culture medium for the rapid cultivation of Helicobacter pylori from biopsy specimens. Eur J Clin Microbiol Infect Dis 27: 1209-1217.
12. Lastovica AJ, le Roux E, (2000) Efficient isolation of campylobacteria from stools. J Clin Microbiol 38: 2798-2799.
13. Kaakoush NO, Holmes J, Octavia S, Man SM, Zhang L, et al. (2010) Detection of Helicobacteraceae in intestinal biopsies of children with Crohn's disease. Helicobacter 15: 549-557.
14. Luber P, Bartelt E, Genschow E, Wagner J, Hahn H, (2003) Comparison of broth microdilution, E Test, and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni and Campylobacter coli. J Clin Microbiol 41: 1062-1068.
15. Vandenberg O, Houf K, Douat N, Vlaes L, Retore P, et al. (2006) Antimicrobial susceptibility of clinical isolates of non-jejuni/coli campylobacters and arcobacters from Belgium. J Antimicrob Chemother 57: 908-913.
16. Loubinoux J, Bronowicki JP, Pereira IA, Mougenel JL, Faou AE, (2002) Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. FEMS Microbiol Ecol 40: 107-112.
17. Urata T, Kikuchi M, Hino T, Yoda Y, Tamai K, et al. (2008) Bacteremia caused by Desulfovibrio fairfieldensis. J Infect Chemother 14: 368-370.
18. Russell RG, O'Donnoghue M, Blake DC Jr, Zulty J, DeTolla LJ, (1993) Early colonic damage and invasion of Campylobacter jejuni in experimentally challenged infant Macaca mulatta. J Infect Dis 168: 210-215.
19. Bereswill S, Kist M, (2002) Molecular microbiology and pathogenesis of Helicobacter and Campylobacter updated: a meeting report of the 11th conference on Campylobacter, Helicobacter and related organisms. Mol Microbiol 45: 255-262.
20. Ketley JM, (1997) Pathogenesis of enteric infection by Campylobacter. Microbiology 143: 5-21.
21. Tom BH, Rutzky LP, Jakstys MM, Oyasu R, Kaye CI, et al. (1976) Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In Vitro 12: 180-191.
22. Konkel ME, Christensen JE, Keech AM, Monteville MR, Klena JD, et al. (2005) Identification of a fibronectin-binding domain within the Campylobacter jejuni CadF protein. Mol Microbiol 57: 1022-1035.
23. Konkel ME, Garvis SG, Tipton SL, Anderson DE Jr, Cieplak W Jr, (1997) Identification and molecular cloning of a gene encoding a fibronectin-binding protein (CadF) from Campylobacter jejuni. Mol Microbiol 24: 953-963.
24. Krause-Gruszczynska M, Rohde M, Hartig R, Genth H, Schmidt G, et al. (2007) Role of the small Rho GTPases Rac1 and Cdc42 in host cell invasion of Campylobacter jejuni. Cell Microbiol 9: 2431-2444.
25. Gunther NWt, Chen CY, (2009) The biofilm forming potential of bacterial species in the genus Campylobacter. Food Microbiol 26: 44-51.
26. Deshpande N, Kaakoush NO, Mitchell H, Janitz K, Raftery MJ, et al. (2011) Sequencing and validation of the genome of a Campylobacter concisus reveals extensive intra-species diversity. PLoS One 6: e22170.
27. Hayes F, (1998) A family of stability determinants in pathogenic bacteria. J Bacteriol 180: 6415-6418.
28. Hardwick JM, (2000) Cyclin' on the viral path to destruction. Nat Cell Biol 2: E203-204.
29. Magowan C, Coppel RL, Lau AO, Moronne MM, Tchernia G, et al. (1995) Role of the Plasmodium falciparum mature-parasite-infected erythrocyte surface antigen (MESA/PfEMP-2) in malarial infection of erythrocytes. Blood 86: 3196-3204.
30. Waller KL, Nunomura W, An X, Cooke BM, Mohandas N, et al. (2003) Mature parasite-infected erythrocyte surface antigen (MESA) of Plasmodium falciparum binds to the 30-kDa domain of protein 4.1 in malaria-infected red blood cells. Blood 102: 1911-1914.
31. Quinn BJ, Welch EJ, Kim AC, Lokuta MA, Huttenlocher A, et al. (2009) Erythrocyte scaffolding protein p55/MPP1 functions as an essential regulator of neutrophil polarity. Proc Natl Acad Sci U S A 106: 19842-19847.
32. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM, (1992) Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J 281 (Pt 1): 21-40.
33. Potempa J, Pike RN, (2009) Corruption of innate immunity by bacterial proteases. J Innate Immun 1: 70-87.
34. Piotrowicz RS, Hickey E, Levin EG, (1998) Heat shock protein 27 kDa expression and phosphorylation regulates endothelial cell migration. FASEB J 12: 1481-1490.
35. Lappalainen P, Drubin DG, (1997) Cofilin promotes rapid actin filament turnover in vivo. Nature 388: 78-82.
36. Jourdain L, Curmi P, Sobel A, Pantaloni D, Carlier MF, (1997) Stathmin: a tubulin-sequestering protein which forms a ternary T2S complex with two tubulin molecules. Biochemistry 36: 10817-10821.
37. Bornslaeger EA, Corcoran CM, Stappenbeck TS, Green KJ, (1996) Breaking the connection: displacement of the desmosomal plaque protein desmoplakin from cell-cell interfaces disrupts anchorage of intermediate filament bundles and alters intercellular junction assembly. J Cell Biol 134: 985-1001.
38. Chikano S, Sawada K, Shimoyama T, Kashiwamura SI, Sugihara A, et al. (2000) IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-γ dependent manner. Gut 47: 779-786.
39. Peters JM, Franke WW, Kleinschmidt JA, (1994) Distinct 19 S and 20 S subcomplexes of the 26 S proteasome and their distribution in the nucleus and the cytoplasm. J Biol Chem 269: 7709-7718.
40. van Deventer S, Neefjes J, (2010) The Immunoproteasome Cleans up after Inflammation. Cell 142: 517-518.
41. Karin M, Ben-Neriah Y, (2000) Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 18: 621-663.
42. Madrid LV, Mayo MW, Reuther JY, Baldwin AS Jr, (2001) Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 276: 18934-18940.
43. Sizemore N, Lerner N, Dombrowski N, Sakurai H, Stark GR, (2002) Distinct roles of the IκB kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-κB) from IκB and in phosphorylating the p65 subunit of NF-κB. J Biol Chem 277: 3863-3869.
44. Dan HC, Cooper MJ, Cogswell PC, Duncan JA, Ting JP, et al. (2008) Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK. Genes Dev 22: 1490-1500.
45. Zhang Z, Huang L, Zhao W, Rigas B, (2010) Annexin 1 induced by anti-inflammatory drugs binds to NF-κB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res 70: 2379-2388.
46. Theiss AL, Jenkins AK, Okoro NI, Klapproth JM, Merlin D, et al. (2009) Prohibitin inhibits tumor necrosis factor alpha-induced nuclear factor-kappa B nuclear translocation via the novel mechanism of decreasing importin alpha3 expression. Mol Biol Cell 20: 4412-4423.
47. Wang Y, Devereux W, Stewart TM, Casero RA Jr, (2002) Polyamine-modulated factor 1 binds to the human homologue of the 7a subunit of the Arabidopsis COP9 signalosome: implications in gene expression. Biochem J 366: 79-86.
48. Song MY, Kim EK, Moon WS, Park JW, Kim HJ, et al. (2009) Sulforaphane protects against cytokine- and streptozotocin-induced beta-cell damage by suppressing the NF-κB pathway. Toxicol Appl Pharmacol 235: 57-67.
49. Bellezza I, Mierla AL, Minelli A, (2010) Nrf2 and NF-κB and Their Concerted Modulation in Cancer Pathogenesis and Progression. Cancers 2: 483-497.
50. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, et al. (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725.
51. Puddu P, Fantuzzi L, Borghi P, Varano B, Rainaldi G, et al. (1997) IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages. J Immunol 159: 3490-3497.
52. Fabunmi RP, Wigley WC, Thomas PJ, DeMartino GN, (2001) Interferon gamma regulates accumulation of the proteasome activator PA28 and immunoproteasomes at nuclear PML bodies. J Cell Sci 114: 29-36.
53. Barton LF, Cruz M, Rangwala R, Deepe GS Jr, Monaco JJ, (2002) Regulation of immunoproteasome subunit expression in vivo following pathogenic fungal infection. J Immunol 169: 3046-3052.
54. Peluso I, Pallone F, Monteleone G, (2006) Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication. World J Gastroenterol 12: 5606-5610.
55. Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, et al. (2004) Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med 351: 2069-2079.
56. Conner EM, Brand S, Davis JM, Laroux FS, Palombella VJ, et al. (1997) Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis. J Pharmacol Exp Ther 282: 1615-1622.
57. Visekruna A, Joeris T, Seidel D, Kroesen A, Loddenkemper C, et al. (2006) Proteasome-mediated degradation of IκBα and processing of p105 in Crohn disease and ulcerative colitis. J Clin Invest 116: 3195-3203.
58. Theiss AL, Idell RD, Srinivasan S, Klapproth JM, Jones DP, et al. (2007) Prohibitin protects against oxidative stress in intestinal epithelial cells. FASEB J 21: 197-206.